Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroya Kitsunai

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Family Medicine and Primary Care|May 21, 2025
The importance of early intervention for chronic subdural hematoma presenting with physical and cognitive dysfunctionHiroya Kitsunai, Hiroshi Nomoto
Mayo Clinic Proceedings|March 16, 2026
Fulminant Type 1 Diabetes Mimicry: "Pseudo-hyperglycemia" Due to Upstream Blood Sampling in a Patient Receiving Immune Checkpoint Inhibitor TherapyHiroya Kitsunai, Fumika Maruyama, Takao Takiyama, et al.
Endocrine Journal|November 19, 2025
Unintentional discontinuation of topical corticosteroids after emergency hospitalization can exacerbate adrenal insufficiencyHiroya Kitsunai, Yumika Watanabe, Eisuke Nishikawa, et al.
Therapeutic Advances in Endocrinology and Metabolism|December 4, 2025
Hypoglycemic coma owing to sensor device dysfunction after an automatic smartphone operating system updateTasuku Sato, Satomi Hashiguchi, Hiroya Kitsunai, et al.
Diabetology International|January 4, 2019
Has the safety of diabetes therapy improved? Lessons from an analysis of diabetic medication-induced severe hypoglycemic cases in an emergency department from 2005 to 2013Akizuki Morikawa, Yuko Morikawa, Masahiro Nomura, et al.
Diabetology International|October 20, 2025
Role of metallothionein 3 in diabetic nephropathy via interplay with HIF-1αYuri Takiyama, Yumi Takiyama, Takao Takiyama, et al.
Scientific Reports|October 16, 2019
Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathyRyoichi Bessho, Yumi Takiyama, Takao Takiyama, et al.
Geriatrics & Gerontology International|October 28, 2025
Deranged Mineral Balance Exacerbated by Concomitant Use of Licorice and Sodium-Glucose Cotransporter-2 Inhibitor in an Older Subject With Impaired Activities of Daily LivingHiroya Kitsunai, Yumika Watanabe, Eisuke Nishikawa, et al.
Metabolic Syndrome and Related Disorders|October 18, 2024
Efficacy of Alogliptin/Metformin Fixed-Dose Combination Tablets and Vildagliptin/Metformin Fixed-Dose Combination Tablets on Glycemic Control in Real-World Clinical Practice for the Patients with Type 2 Diabetes: A Multicenter, Open-Label, Randomized, Parallel Group, Comparative TrialTomoe Abe, Yasutaka Takeda, Ichiro Sakuma, et al.
Clinical Journal of Gastroenterology|June 9, 2026
Doege-Potter syndrome caused by a solitary fibrous tumor arising from the greater omentum: a case reportTomoki Takizawa, Tatsuya Shonaka, Chikayoshi Tani, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Family Medicine and Primary Care|May 21, 2025
The importance of early intervention for chronic subdural hematoma presenting with physical and cognitive dysfunctionHiroya Kitsunai, Hiroshi Nomoto
Mayo Clinic Proceedings|March 16, 2026
Fulminant Type 1 Diabetes Mimicry: "Pseudo-hyperglycemia" Due to Upstream Blood Sampling in a Patient Receiving Immune Checkpoint Inhibitor TherapyHiroya Kitsunai, Fumika Maruyama, Takao Takiyama, et al.
Endocrine Journal|November 19, 2025
Unintentional discontinuation of topical corticosteroids after emergency hospitalization can exacerbate adrenal insufficiencyHiroya Kitsunai, Yumika Watanabe, Eisuke Nishikawa, et al.
Therapeutic Advances in Endocrinology and Metabolism|December 4, 2025
Hypoglycemic coma owing to sensor device dysfunction after an automatic smartphone operating system updateTasuku Sato, Satomi Hashiguchi, Hiroya Kitsunai, et al.
Diabetology International|January 4, 2019
Has the safety of diabetes therapy improved? Lessons from an analysis of diabetic medication-induced severe hypoglycemic cases in an emergency department from 2005 to 2013Akizuki Morikawa, Yuko Morikawa, Masahiro Nomura, et al.
Diabetology International|October 20, 2025
Role of metallothionein 3 in diabetic nephropathy via interplay with HIF-1αYuri Takiyama, Yumi Takiyama, Takao Takiyama, et al.
Scientific Reports|October 16, 2019
Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathyRyoichi Bessho, Yumi Takiyama, Takao Takiyama, et al.
Geriatrics & Gerontology International|October 28, 2025
Deranged Mineral Balance Exacerbated by Concomitant Use of Licorice and Sodium-Glucose Cotransporter-2 Inhibitor in an Older Subject With Impaired Activities of Daily LivingHiroya Kitsunai, Yumika Watanabe, Eisuke Nishikawa, et al.
Metabolic Syndrome and Related Disorders|October 18, 2024
Efficacy of Alogliptin/Metformin Fixed-Dose Combination Tablets and Vildagliptin/Metformin Fixed-Dose Combination Tablets on Glycemic Control in Real-World Clinical Practice for the Patients with Type 2 Diabetes: A Multicenter, Open-Label, Randomized, Parallel Group, Comparative TrialTomoe Abe, Yasutaka Takeda, Ichiro Sakuma, et al.
Clinical Journal of Gastroenterology|June 9, 2026
Doege-Potter syndrome caused by a solitary fibrous tumor arising from the greater omentum: a case reportTomoki Takizawa, Tatsuya Shonaka, Chikayoshi Tani, et al.
Pageof 2